June 13, 2025

FDA Approves Immune Checkpoint Inhibitor Drug for Patients With Resectable Locally Advanced Head and Neck Cancer

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck squamous cell carcinoma whose tumors express PD-L1 [Combined Positive Score (CPS) ?1] as determined by an FDA-approved test.

Dana-Farber

February 06, 2025

Otolaryngology – Head and Neck Surgery 2025

World leaders in tracheal transplantation, HPV-associated oropharyngeal cancer treatment, endoscopic ear and skull base surgery, and virtual reality for education and surgical planning, our team has forged groundbreaking diagnostics, treatments and technological advances in this exciting field.

Mount Sinai New York

September 28, 2023

Gaining Unique Insight Into Thyroid Cancer Among World Trade Center Survivors

Maaike van Gerwen, MD, PhD is heading two novel studies that could lead to a better understanding of thyroid cancer among patients exposed to toxins during the World Trade Center (WTC) attacks.

Mount Sinai New York

August 04, 2023

Join Mount Sinai for the Seventh Annual Endoscopic Middle Ear Surgery Dissection CME Course

Course material and hands-on laboratory dissection will be appropriate for both novice and advanced endoscopic ear surgeons. For those unable to travel to New York City, this course also contains a virtual lecture component.

Mount Sinai New York

June 22, 2023

Collaboration Brings Best Treatment Options for Acoustic Neuroma

Sudden hearing loss is usually linked to cochlear inflammation but may, in rare cases, indicate the presence of an acoustic neuroma, or vestibular schwannoma. And when it comes to acoustic neuroma surgery, two sets of eyes on an ear can make all the difference.

Cedars-Sinai Pulse

April 08, 2024

Voice Recovery Options After Total Laryngectomy: Which Is Best for a Patient?

Total laryngectomy patients have several options for regaining voice functioning. Ensuring best outcomes takes a team, explains Niels C. Kokot, MD, an otolaryngologist at the USC Head and Neck Center, part of USC Caruso Ear, Nose & Throat

Keck Medicine of USC

February 10, 2023

Endowed Research Fellowships for Students Interested in Otolaryngology

Otolaryngology residencies are increasingly in demand. The Department of Otolaryngology – Head and Neck Surgery at the Icahn School of Medicine at Mount Sinai offers four fellowships for third- and fourth-year medical students.

Mount Sinai New York

February 10, 2023

Facial Plastic Surgery Division Revives 100-Year-Old Rhinoplasty Technique With Cutting-Edge Results

The standard procedure for rhinoplasty has remained popular with facial plastic surgeons for more than a century, despite some of its known risks and limitations.

Mount Sinai New York

March 20, 2023

Genetic Causes of Three Previously Unexplained Rare Diseases Identified

Mount Sinai researchers help identify previously unknown genetic causes of primary lymphedema, thoracic aortic aneurysm disease, and congenital deafness.

Mount Sinai New York